Verified Peptide ReviewLast reviewed: 26 February 2026
Compound Profile · Cognitive
Selank
Selank is a synthetic heptapeptide developed in Russia, studied for anxiolytic and nootropic-style effects.
LegalResearch onlyEvidenceEmergingHuman useNot approved
7.2/ 10
Peptide Score
Evidence
Safety
Regulatory
Transparency
Quick verdict
Most published literature is in Russian. Small clinical signal, limited replication elsewhere.
Reality check
What this isn't
- Not approved for human use — research-only context
- No regulator has approved human use
- Evidence base is early — long-term data limited
- Side-effect profile not fully characterised
- Educational only — not medical advice
Full Selank review
A heptapeptide based on a fragment of tuftsin.
Looking at alternatives?
Compounds with comparable research interest but different evidence, regulatory status, or risk profile.